Vaccines and COVID-19: Oxford University to examine the reaction of COVID vaccines in children
The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca in children for the first time.
Researchers will use 300 volunteers to assess whether the jab – known as the the ChAdOx1 nCoV-19 vaccine – produces a strong immune response in children aged between 6 and 17.
About 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.
“There is also some evidence that children may be less likely to acquire the infection. The role of children in transmission, once they have acquired the infection, is unclear, although there is no clear evidence that they are any more infectious than adults.”
The two-dose Oxford-AstraZeneca vaccine has been hailed as a “vaccine for the world” because it is cheaper and easier to distribute than some rivals.
Rinn Song, paediatrician and clinician-scientist at the Oxford Vaccine Group, said: “The Covid-19 pandemic has had a profound negative impact on the education, social development and emotional wellbeing of children and adolescents, beyond illness and rare severe disease presentations.